Analyst Ryan MacDonald from Needham maintained a Buy rating on Phreesia (PHR – Research Report) and keeping the price target at $29.00.Stay ...

Citi raised the firm’s price target on Phreesia (PHR) to $35 from $31 and keeps a Buy rating on the shares as part of a 2025 outcook for the ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $31.0, a high ...

Analyst predicts Phreesia's revenue per client will accelerate, as company shifts focus to monetizing existing clients.

Fintel reports that on January 8, 2025, RBC Capital upgraded their outlook for Phreesia (NYSE:PHR) from Sector Perform to ...

From a technical perspective, Phreesia, Inc. (PHR) is looking like an interesting pick, as it just reached a key level of support. PHR's 50-day simple moving average crossed above its 200-day simple ...

Phreesia (NYSE:PHR – Get Free Report) had its target price raised by investment analysts at KeyCorp from $28.00 to $30.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage ...

Pre-Market: 8:17:00 a.m. EST ...

Over the last 7 days, the United States market has remained flat, yet it has experienced a significant rise of 23% over the past 12 months, with earnings expected to grow by 15% per annum in the ...

National American University Holdings Inc (NAUH) is expected to report for 2Q. Neogen Corp (NEOG) is expected to report $-0.01 for 2Q. NexImmune Inc (NEXI) is expected to report for 3Q.